Validation of the Triaxial Accelerometer for the Evaluation of Physical Activity in Japanese Patients with COPD
スポンサーリンク
概要
- 論文の詳細を見る
Objective The quantification of physical activity is useful for the management of chronic obstructive pulmonary disease (COPD) but has not been fully established yet. The DynaPort Activity Monitor® (DAM), a triaxial accelerometer is the only well validated accelerometer in Caucasians but it has not been validated in Japanese COPD patients. We initially evaluated the reproducibility of the DAM in Japanese healthy subjects. Next, the within-subject repeatability and the determinants of physical activity were investigated in Japanese COPD patients. Materials and Methods The durations of locomotion, standing, and sitting measured by the DAM were compared to those of the self-records (Study 1). COPD patients wore the DAM for 3 days and the durations of each activity of 2 selected days were compared to assess the repeatability (Study 2). The relationship between the duration of locomotion and the physiological properties were examined (Study 3). Results The activities measured by the DAM were significantly associated with those of the self-records (p<0.001). The values of the intra-class correlation coefficient (ICC) for the reproducibility were over 0.99, and the agreement with the self-records was observed for the DAM. Similarly, the values of ICC for repeatability were over 0.84 in all activities, and there was no systematic bias in the COPD patients. The duration of locomotion was negatively correlated with the total lung capacity (TLC) and closing capacity/TLC, but not with other pulmonary functions, exercise capacity, muscle force, dyspnea, or modified BODE index. Conclusion The triaxial accelerometer is reliable for evaluating the physical activity of Japanese COPD patients.
著者
-
Ichinose Masakazu
The Third Department Of Internal Medicine Wakayama Medical University
-
MINAKATA Yoshiaki
the Third Department of Internal Medicine, Wakayama Medical University, School of Medicine
-
Ichikawa Tomohiro
The Third Department of Internal Medicine, Wakayama Medical University, School of Medicine, Japan
-
Ichikawa Tomohiro
The Third Department of Internal Medicine, Wakayama Medical University
-
Matsunaga Kazuto
The Third Department of Internal Medicine, Wakayama Medical University, School of Medicine
-
Kanda Masae
The Third Department of Internal Medicine, Wakayama Medical University, School of Medicine
-
Akamatsu Keiichiro
The Third Department of Internal Medicine, Wakayama Medical University, School of Medicine
-
Koarai Akira
The Third Department of Internal Medicine, Wakayama Medical University, School of Medicine
-
Hirano Tsunahiko
The Third Department of Internal Medicine, Wakayama Medical University, School of Medicine
-
Sugiura Hisatoshi
The Third Department of Internal Medicine, Wakayama Medical University, School of Medicine
-
Kanda Masae
The Third Department of Internal Medicine, Wakayama Medical University, School of Medicine, Japan
-
Kanda Masae
The Third Department of Internal Medicine, Wakayama Medical University
-
Koarai Akira
The Third Department of Internal Medicine, Wakayama Medical University, School of Medicine, Japan
-
Koarai Akira
The Third Department of Internal Medicine, Wakayama Medical University
-
Hirano Tsunahiko
The Third Department of Internal Medicine, Wakayama Medical University, School of Medicine, Japan
-
Hirano Tsunahiko
The Third Department of Internal Medicine, Wakayama Medical University
-
Akamatsu Keiichiro
The Third Department of Internal Medicine, Wakayama Medical University, School of Medicine, Japan
-
Akamatsu Keiichiro
The Third Department of Internal Medicine, Wakayama Medical University
-
Matsunaga Kazuto
The Third Department of Internal Medicine, Wakayama Medical University, School of Medicine, Japan
-
Matsunaga Kazuto
The Third Department of Internal Medicine, Wakayama Medical University
-
Sugiura Hisatoshi
The Third Department of Internal Medicine, Wakayama Medical University
-
Minakata Yoshiaki
The Third Department of Internal Medicine, Wakayama Medical University, School of Medicine, Japan
-
Minakata Yoshiaki
The Third Department of Internal Medicine, Wakayama Medical University
関連論文
- Rapid Intrahepatic Tumor Seeding after Percutaneous Ethanol Injection Therapy for Hepatocellular Carcinoma
- Serum Antibody Against Granulocyte/Macrophage Colony-Stimulating Factor and KL-6 in Idiopathic Pulmonary Alveolar Proteinosis
- Long-Term Use of Corticosteroid Eye Drops Delays the Spontaneous Remission of Pulmonary Sarcoidosis
- High COPD Prevalence in Patients with Liver Disease
- Peak Expiratory Flow Variability Adjusted by Forced Expiratory Volume in One Second is a Good Index for Airway Responsiveness in Asthmatics
- Efficacy and Safety of Formoterol in Japanese Patients with COPD
- Change in Cytokeratin 19 Fragment Level According to the Severity of Pulmonary Alveolar Proteinosis
- Validation of the Triaxial Accelerometer for the Evaluation of Physical Activity in Japanese Patients with COPD
- 2. Advances in Pharmacotherapy for COPD